What is Semble?
Semble Technology is dedicated to advancing healthcare through technological innovation. The company focuses on enhancing operational efficiencies, accelerating medical and administrative tasks, improving system interoperability, streamlining patient engagement, and leveraging data analytics. By empowering clinical teams, Semble Technology aims to redefine care delivery and contribute to the transformation of the healthcare industry.
How much funding has Semble raised?
Semble has raised a total of $58.5M across 1 funding round:
Series B
$15M
Series B (2024): $15M with participation from Octopus Ventures and Triple Point
Key Investors in Semble
Octopus Ventures
Octopus Ventures is a founder-focused venture capital firm that backs mission-driven companies across software, climate, health, consumer, and financial technology, offering long-term capital, guidance, and community.
Triple Point
Founded in 2004, Triple Point is an FCA-regulated investment management firm managing institutional and public capital across infrastructure, property, debt, and venture capital.
What's next for Semble?
The recent major strategic investment positions Semble Technology for accelerated growth and further development of its innovative healthcare solutions. This capital will likely fuel expansion into new markets, enhance product development, and strengthen strategic partnerships. The company's focus on operational efficiency and data utilization suggests a trajectory aimed at becoming a key player in the digital health transformation, potentially leading to further enterprise-level funding rounds as it scales its impact.
See full Semble company page
